Nicolas Bouvier has been an Art Director and Concept Artist since 1996 producing works for film and gaming. He currently lives in Seattle and works for Microsoft. He draws his influences from various sources and cultures which range from space, architecture, robotics and beyond.
This is a friendly reminder not to forget about the downright knockdown dragout kickass studio known as Invisible Creature. We have been knee deep in motion design and 3D lately at our studio but seeing Invisible Creature’s new work makes me want to roll up my sleeves and get my hands dirty with print again. Their work has been an inspiration to me for several years now and every update to their portfolio yields a new source for that inspiration.
Seattle-based design powerhouse Invisible Creature has relaunched and updated with more and more and more spectacular work that is genuinely inspirational. They really know what they are doing and are at the top of their game. It’s rare that art and design meld so perfectly that you have a hard time distinguishing where one ends and the other begins.
05/18 SENDAK PASSES The brilliant author and illustrator Maurice Sendak passed away last week at the age of 83 but will no doubt be remembered for generations to come for his amazing books such as Where the Wild Things Are.
04/12 ZIMMERMAN FACES MURDER In a case we’ve been following closely there is finally what we think is some good news to report. George ZImmerman, the man accused of killing the innocent teenager Trayvon Martin has been taken into custody and charged with second degree murder. At last there is some justice.
12/16 HITCHENS DIES Outspoken author and pundit Christopher Hitchens passed away yesterday at the age of 62 after succombing to a long battle with cancer. His honest and bravado opinion that rarely favored one side versus the other but was instead often a cry for ‘reason’ will be missed.
11/23 BURZYNKSI CLINIC Is there an alternative, non-toxic treatment for cancer? Dr. Stanislaw R. Burzynski seems to think so and has been experiencing higher rate of success than the current accepted practice of treating cancer.